BioCentury | Jul 12, 2019
Financial News
HitGen joins growing Shanghai IPO queue
...and research institutes, as reflected by its deal with Adam Zhao’s Anlong Fund to form NetVation DL Medicine...
...Histone deacetylase 1; HDAC2 - Histone deacetylase 2 Hongjiang Li, Staff Writer HG146 Almirall S.A. Gilead Sciences Inc. HitGen Ltd. NetVation DL Medicine Nuevolution...
...Histone deacetylase 1; HDAC2 - Histone deacetylase 2 Hongjiang Li, Staff Writer HG146 Almirall S.A. Gilead Sciences Inc. HitGen Ltd. NetVation DL Medicine Nuevolution...